drugset / Trial / NCT07474077

Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH

NCT07474077

Phase 3 Not yet recruiting 88 enrolled Sultan Qaboos University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Investigating the efficacy of tranexamic acid (TXA) as a prophylactic agent in reducing postpartum haemorrhage (PPH) among patients undergoing cesarean section (CS) in SQUH: a prospective randomized controlled trial.

Timeline

Start
2026-05-01
Primary completion
2027-12-31
Completion
2028-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.